Research Article

KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico

Figure 1

Distribution of activating/inhibitory KIR gene number between SSc patients and CS. (a) The number of activating KIR (aKIR) gene number percentage in SSc patients (gray circle) and CS (white triangles) is shown. (b) The number of inhibitory KIR (iKIR) gene number percentage in SSc patients (gray circle) and CS (white triangles) is shown. (c) The genotypes with higher iKIR than aKIR () is indicated according to the number of iKIR and aKIR genes present. SSc: Systemic Sclerosis; CS: Control Subjects; based on Fisher’s exact test and , based on Holm-Bonferroni correction for multiple comparisons.
(a)
(b)
(c)